http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012128776-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate | 2010-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012128776-A |
| titleOfInvention | COMBINED DRUGS WITH CYTOKINE ANTAGONIST AND CORTICOSTEROID |
| abstract | 1. A pharmaceutical composition comprising a corticosteroid together with a cytokine antagonist and optionally a growth factor, wherein the cytokine antagonist consists of a mixture of the naturally occurring IL-1Ra protein and a recombinant protein IL-1Ra, in particular Orthokine or Anakinra, and this pharmaceutical composition is suitable for local administration. 2. A pharmaceutical composition comprising a cytokine antagonist and optionally a growth factor for use in combination therapy with a corticosteroid, wherein the cytokine antagonist consists of a mixture of a naturally-occurring IL-1Ra protein and a recombinant protein IL-1Ra, in particular Orthokine or Anakinra, and this pharmaceutical the composition is suitable for local administration. 3. The pharmaceutical composition according to claim 2, wherein the pharmaceutical composition is intended for the simultaneous or sequential administration of a cytokine antagonist / growth factor and a corticosteroid. A pharmaceutical composition comprising a corticosteroid for use in combination therapy together with a cytokine antagonist and optionally a growth factor, the cytokine antagonist consisting of a mixture of the naturally occurring IL-1Ra protein and a recombinant IL-1Ra protein, in particular Ortokine or Anakinra, this pharmaceutical the composition is suitable for local administration. 5. The pharmaceutical composition according to claim 4, wherein the pharmaceutical composition is intended for the simultaneous or sequential administration of a cytokine antagonist or growth factor and corticosteroid. The pharmaceutical composition according to any one of claims 1 to 5, including an additional cytokine antagonist selected from |
| priorityDate | 2009-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 150.